Search - tctmd.com

Displaying 21 - 40 of 250

Sort: Relevancy | Date

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

News Conference News ACC 2024

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Shelley Wood

April 07, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

Todd Neale

January 21, 2024

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Conference News AHA 2023

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

Todd Neale

November 13, 2023

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

News Daily News

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

L.A. McKeown

October 10, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

L.A. McKeown

September 25, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

Advertisement

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Think You Need a Statin? AHA’s Risk Calculator May Disagree

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Statins Effective For Primary Prevention in Old and Very Old

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

AHA Selects 2023’s Leading Cardiovascular Research

Who Benefits Most From Semaglutide and How Long Will That Take?

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study

October 2023 News Roundup

Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content